Assay precision of serum α fetoprotein in antenatal screening for neural tube defects and Down's syndrome

Abstract

Improvements in the precision of maternal serum AFP measurement have led to small but useful improvements in screening for open neural tube defects and Down's syndrome. Published estimates of screening performance using such modern assays can be revised accordingly.